QxAApp

Perioperative management and procedure of antithrombotic treatment

This app is for professional use by medical personnel, please consult with a doctor before making any decision about your treatment.

Application developed by the Spanish Society of Cardiology (SEC) to offer practical recommendations to physicians who assist patients with antithrombotic treatment before a surgery or interventional procedure. The app bases its algorithm on the consensus document "Perioperative management and periprocedimiento of antithrombotic treatment" (Rev Esp Cardiol. 2018; 71: 553-64), coordinated by the Working Group on Cardiovascular Thrombosis of the SEC and certified by a broad number of scientific societies that participate in the patient's care process, in order to standardize daily clinical practice.

Surgical or interventional procedures are increasingly common in anticoagulated and antiaggregated patients that may require the interruption of chronic antithrombotic treatment. The decision to withdraw or maintain such treatment is determined by the risk of thrombosis or hemorrhagic risk and the interaction between these two factors.

QxAApp offers professionals, in a practical and simple way, answers to questions such as whether it is necessary to stop anticoagulation and, in such a case, when; if bridging therapy is necessary, when and how to reintroduce anticoagulation or antiplatelet therapy; how to proceed before an urgent surgery, etc.

The application is articulated through a test in different steps, without needing registration and without saving the information that you consult to deduce the recommendation:

 • Type of treatment and drugs. The user doctor indicates which treatment the patient is following, whether anticoagulant or antiaggregant, and selects the drugs. Depending on the selection, the app will identify the patient's thrombotic and hemorrhagic risk, classifying it as "high", "medium" or "low".

 • Heart disease and patient characteristics. The type of heart disease, the patient's characteristics and their risks are detailed below.

 • Type of intervention and hemorrhagic risk. The application gives a choice between different types of surgical intervention to which the patient will be submitted among five categories.

 • Summary and conclusions. The app indicates how many days before the intervention the patient is recommended to take the last dose of drugs, if a bridge therapy is considered necessary and, finally, when it should be introduced. new the treatment after the intervention.